Correction: Identification of a novel quinoline-based DNA demethylating compound highly potent in cancer cells

Affiliations

• ¹ Department of Chemistry and Technologies of Drugs, Sapienza University of Rome, P.le A. Moro 5, 00185, Rome, Italy.
• ² Laboratoire de Biologie Moléculaire et Cellulaire du Cancer, Hôpital Kirchberg, 9 rue Edward Steichen, L-2540, Luxembourg City, Luxembourg.
• ³ Department of Medicine of Precision, University of Studi della Campania Luigi Vanvitelli, Vico L. De Crecchio 7, 80138, Naples, Italy.
• ⁴ Department of Molecular Medicine, Sapienza University of Rome, Viale Regina Elena 324, 00161, Rome, Italy.
• ⁵ Laboratory of Experimental Oncology, IRCCS - Istituto Ortopedico Rizzoli, via di Barbiano, 1/10, 40136, Bologna, Italy.
• ⁶ Center for High-Throughput Chemical Biology, Simon Fraser University, 8888 University Drive, Burnaby, BC, V5A 1S6, Canada.
• ⁷ Pierre Fabre Laboratories, 3 Avenue Hubert Curien, 31100, Toulouse, France.
• ⁸ National Institute for Infectious Diseases L. Spallanzani, IRRCCS, Via Portuense, 292, 00149, Rome, Italy.
• ⁹ Division of Epigenomics, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
• ¹⁰ Pasteur Institute, Cenci-Bolognetti Foundation, Sapienza University of Rome, P.le A. Moro 5, 00185, Rome, Italy.
• ¹¹ Epigenetic Chemical Biology, Institut Pasteur, CNRS UMR3523, 28 rue du Docteur Roux, 75724, Paris, France.
• ¹² Department of Pharmacy, Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, 1 Gwanak-ro, Gwanak-gu, 08826, Korea.
• ¹³ Department of Chemistry and Technologies of Drugs, Sapienza University of Rome, P.le A. Moro 5, 00185, Rome, Italy. antonello.mai@uniroma1.it.
• ¹⁴ Pasteur Institute, Cenci-Bolognetti Foundation, Sapienza University of Rome, P.le A. Moro 5, 00185, Rome, Italy. antonello.mai@uniroma1.it.
• ¹⁵ Department of Chemistry and Technologies of Drugs, Sapienza University of Rome, P.le A. Moro 5, 00185, Rome, Italy. sergio.valente@uniroma1.it.